
---
title: '北陆药业：钆布醇注射液获得药品注册证书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6843'
author: 证券时报网
comments: false
date: Thu, 07 Apr 2022 16:39:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6843'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300016" style="color: #2f67d1;text-decoration: none;" code="300016" target="_blank">北陆药业</a>(300016)4月7日晚间公告，今日收到国家药品监督管理局核准签发的钆布醇注射液《药品注册证书》。钆布醇注射液可用在全身各部位（包括颅脑和脊髓）病变的磁共振增强检查。</p>

                  
</div>
            